Abstract
Objective: To compare the effects of intravenous methylprednisolone (IVMP) in patients with relapsing-remitting (RR-MS), secondary progressive (SP-MS), and primary progressive multiple sclerosis (PP-MS). Methods: Clinical and neurophysiological follow up was...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have